This is a Validated Antibody Database (VAD) review about human TCL1, based on 4 published articles (read how Labome selects the articles), using TCL1 antibody in all methods. It is aimed to help Labome visitors find the most suited TCL1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TCL1 synonym: TCL1; T-cell leukemia/lymphoma protein 1A; T-cell lymphoma-1; oncogene TCL-1; oncogene TCL1; protein p14 TCL1

Santa Cruz Biotechnology
mouse monoclonal (1-21)
  • western blot; human; fig 4b
In order to generate and characterize a human myeloma cell line, Santa Cruz Biotechnology TCL1 antibody (Santa Cruz Biotechnology, sc-32331) was used in western blot on human samples (fig 4b). Int J Hematol (2015) ncbi
Invitrogen
mouse monoclonal (1 21)
  • western blot; human; 1:1000
In order to identify proteins associated with chronic lymphocytic leukemia, Invitrogen TCL1 antibody (Invitrogen, 39-4800) was used in western blot on human samples at 1:1000. J Proteome Res (2014) ncbi
mouse monoclonal (1 21)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to investigate the correlation between miR-223 expression and gastric MALT lymphoma, Invitrogen TCL1 antibody (Zymed Laboratories, clone 1-21) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). Mod Pathol (2010) ncbi
Cell Signaling Technology
rabbit polyclonal
  • western blot; mouse; 1:1000; fig 4
Cell Signaling Technology TCL1 antibody (Cell Signaling, 4042) was used in western blot on mouse samples at 1:1000 (fig 4). Leukemia (2016) ncbi
Articles Reviewed
  1. Chen S, Chang B, Chang S, Tong T, Ham S, Sherry B, et al. BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia. Leukemia. 2016;30:833-43 pubmed publisher
  2. Mizuno S, Hanamura I, Ota A, Karnan S, Narita T, Ri M, et al. Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells. Int J Hematol. 2015;102:569-78 pubmed publisher
  3. Alsagaby S, Khanna S, Hart K, Pratt G, Fegan C, Pepper C, et al. Proteomics-based strategies to identify proteins relevant to chronic lymphocytic leukemia. J Proteome Res. 2014;13:5051-62 pubmed publisher
  4. Liu T, Chen S, Kuo S, Cheng A, Lin C. E2A-positive gastric MALT lymphoma has weaker plasmacytoid infiltrates and stronger expression of the memory B-cell-associated miR-223: possible correlation with stage and treatment response. Mod Pathol. 2010;23:1507-17 pubmed publisher